[{"id":"d92c2904-fae5-49ae-88c5-673b584f9118","acronym":"","url":"https://clinicaltrials.gov/study/NCT04872543","created_at":"2022-03-16T22:55:47.285Z","updated_at":"2024-07-02T16:35:16.749Z","phase":"Phase 2","brief_title":"A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)","source_id_and_acronym":"NCT04872543","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" SUZ12","pipe":" | ","alterations":" EZH2 mutation","tags":["SUZ12"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EZH2 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Inqovi (decitabine/cedazuridine)"],"overall_status":"Recruiting","enrollment":" Enrollment 25","initiation":"Initiation: 04/29/2021","start_date":" 04/29/2021","primary_txt":" Primary completion: 04/01/2026","primary_completion_date":" 04/01/2026","study_txt":" Completion: 04/01/2026","study_completion_date":" 04/01/2026","last_update_posted":"2024-03-01"}]